Population
231 serum samples from healthy individuals in Okayama Prefecture, Japan, plus 4 paired serum specimens from…
Comparison
Neutralization assay for human group C rotavirus… vs Indirect immunofluorescence test
Design
Preclinical
Authors
Loading...
N-RPHA validates as a scalable CHRV serosurvey tool; leaves open its diagnostic or vaccine-monitoring utility pending clinical studies.
The N-RPHA test is the first system developed to assay for a neutralization antibody against human group C rotavirus, demonstrating high correlation with immunofluorescence and applicability in epidemiological settings.
Fujii et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: